Elligo Health Research, a prominent clinical research technology platform based in Austin, Texas, has successfully secured a significant venture loan facility of $40 million from Horizon Technology Finance (NASDAQ: HRZN). The infusion of funds will be strategically allocated towards supporting the company's overall growth initiatives and enhancing its working capital, solidifying its mission to accelerate clinical trials by providing direct access to a diverse and well-profiled patient base across numerous hospitals, health systems, and research sites through their innovative IntElligo technology and PatientSelect® model.